medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Número 4

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (4)


Dermatomiositis juvenil paraneoplásica. Reporte de un caso asociado a linfoma y revisión de la literatura

Poletti ED, Leal AVM, Muñoz SR, Muñoz FL, Morales MA

Idioma: Español
Referencias bibliográficas: 36
Paginas: 263-267
Archivo PDF: 236.68 Kb.


RESUMEN

Se trata de un adolescente masculino de 13 años de edad con diagnóstico de dermatomiositis juvenil asociada a linfoma no- Hodgkin, como evento paraneoplásico. La dermatomiosistis es una enfermedad multisistémica del tejido conjuntivo-vascular, como expresión de una miopatía inflamatoria cuya etiopatogenia aún es desconocida, por lo que se han propuesto múltiples teorías y asociaciones, incluida la neoplásica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fernández-Bussy R, Gatti CF, Porta-Guardia C. Fundamentos en Dermatología Clínica. 1a ed. Argentina, Ediciones Journal, 2011: 229-239.

  2. Jorrizo JL: “Dermatomiositis”. En: Bolognia JL, Jorrizo JL, Rapini RP. Dermatología. Madrid, Elsevier. España, 2008, 622-627.

  3. Feldman BM, Rider LG, Reed AM, Pachman LM. “Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood”. Lancet 2008; 371: 2201-2212.

  4. Callen JP, Jorizzo J, Bolognia J, Piette WW, Zone JJ. “Dermatomyositis”. En: Vieugels RA, Callen JP. Dermatological signs of Internal Medicine. Philadelphia, Saunders, 2009, 11-19 y 107-116.

  5. Bohan A, Peter JB. “Polymyositis and dermatomyiositis (first of two parts)”. N Engl J Med 1975; 292: 344-347.

  6. Brown VE, Pilkington CA, Feldman BM, Davidson JE. “Network for Juvenile Dermatomyositis, Paediatric Rheumatology European Society (PReS). An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)”. Rheumatology (Oxford) 2006; 45(8): 990-993.

  7. Feldman BM, Rider LG, Reed AM, Pachman LM. “Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood”. Lancet 2008; 28, 371 (9631):2201-2212.

  8. Schmieder A, von Komorowski G, Peitsch WK, Goerdt S, Goebeler M. “Juvenile dermatomyositis in an 8-year-old boy”. Dermatology Online Journal 2009; 15(6): 3.

  9. Reed AM, López M. “Juvenile dermatomyositis: recognition and treatment”. Pediatric Drugs 2002; 4: 315-321.

  10. Ravelli A, Ruperto N, Trail L, Felici E, Sala E, Martini A. “Clinical assessment in juvenile dermatomyositis”. Autoimmunity 2006; 39: 197- 203.

  11. Ramanan AV, Feldman BM. “Clinical outcomes in juvenile dermatomyositis”. Curr Opin Rheumatol 2002; 14: 658-662.

  12. Vose J, Chiu BC, Cheson BD. “Update on epidemiology and therapeutics for non-Hodking´s lymphoma”. Hematology 2002; 241-261.

  13. Levi F, Randimbison L, Te VC, La Vecchia C. “Non-Hodgkin’s lymphomas, chronic lymphocytic leukaemias and skin cancers”. Br J Cancer 1996; 74:1847-1850.

  14. Harris LN, Stein H, Coupland SE, Hummel M, Favre RD. “New approaches to lymphoma diagnosis”. Hematology 2001; 194-220.

  15. Callen JP. “Myositis and malignancy”. Curr Opin Rheumatol 1994; 6: 590- 594.

  16. Curth HO. “Skin lesions and internal carcinoma”. En: Andrade R, Gumport SL, Popkin GI, et al. Cancer of the skin. Philadelphia, Saunders, 1976, 1308-1343.

  17. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. “Frequency of specific cancer types in dermatomyositis and polimyositis: a population-based study”. Lancet 2001; 357: 85-86.

  18. Barnes BE, Mawr B. “Dermatomyositis and malignancy. A review of the literature”. Ann Intern Med 1976; 84: 68-76.

  19. Chung VQ, Moschella SL, Zembowicz A, Liu V. “Clinical and pathologic findings of paraneoplastic dermatoses”. J Am Acad Dermatol 2006; 54: 745-762

  20. Cox NH, Lawrence CM, Langtry JA, Ive FA. “Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy”. Arch Dermatol 1990; 126: 61-65.

  21. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992; 326: 363-7.

  22. Sparsa A, Liozon E, Hermann F, et al. “Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients”. Arch Dermatol 2002; 138: 885-890.

  23. Poletti ED. El A, B, C, cutáneo del Internista. 1ª ed. México, Alfil, 2009: 34-36.

  24. Cohen PR. “Cutaneous paraneoplastic síndromes”. Adv Dermatol 1995; 11: 215-252.

  25. Morris P. “Juvenile dermatomyositis as a paraneoplastic phenomenon: an update”. J Pediatr Hematol Oncol 2010; 3: 189-191.

  26. Richardson JB, Callen JP. “Dermatomyositis and malignancy”. Med Clin North Am 1989; 73: 1211-1220.

  27. Caldwell DS, McCallum RM. “Rheumatologic manifestations of cancer”. Med Clin North Am 1986; 70: 385-417.

  28. Zappasodi P, Del Forno C, Corso A, Lazzarino M. “Mucocutaneous paraneoplastic syndromes in hematologic malignancies”. Int Jou Dermatol 2006; 45, 14-22.

  29. Chen YJ, Wu CY, Shen JL. “Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study”. Br J Dermatol 2001; 144: 825-831.

  30. Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revuz J. Touraine R. “Prognosis factors and predictive signs of malignancy in adult dermatomyositis”. Arch Dermatol 1990; 126: 633-637.

  31. Burnouf M, Mahé E, Verpillat P, et al. Cutaneous necrosis is predictive of cancer in adult dermatomyositis. Ann Dermatol Venereol 2003; 130 (3): 313-16.

  32. Gallais V, Crickx B, Belaïch S. « Facteurs pronostiques et signes prédictifs de cancer au cours de la dermatomyosite de l’adulte ». Ann Dermatol Venereol 1996; 123: 722-726.

  33. Mautner GH, Grossman ME, Silvers DN, Rabinowitz A, Mowad CM, Johnson BL. “Epidermal necrosis as a predictive sign of malignancy in adult dermatomyositis”. Cutis 1998; 61: 190-194.

  34. Prohic A, Kasumagic-Halilovic E, Simic D, Selmanagic A. “Clinical and biological factors predictive of malignancy in dermatomyositis.” JEADV 2009, 23, 570-620.

  35. Sontheimer RD, Provost TT. Cutaneous Manifestations of Rheumatic Diseases. 1a ed. Philadelphia, Lippincott Williams& Wilkins, 2004: 65-98.

  36. Hiketa T, Matsumoto Y, Ohashi M, et al. “Juvenile dermatomyositis, a statistical study of 114 patients with dermatomyositis”. J dermatolol 1992; 19: 470-476.




2020     |     www.medigraphic.com